This analysis strengthens the conclusions that, in patients with open-angle glaucoma or ocular hypertension, (combination Azopt 1%/Alphagan 0.2% had significantly superior IOP-lowering activity compared with either Azopt or Alphagan alone and a safety profile (20.1% adverse reaction rate) consistent with that of its individual components.
No comments:
Post a Comment
Leave a Comment or Question: